Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Development of Next-Generation COVID-19 Vaccines: Biomedical Advanced Research and Development Authority (BARDA-)-Supported Phase 2b Study Designs.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: April 24, 2024
Functional properties of measles virus proteins derived from a subacute sclerosing panencephalitis patient who received repeated remdesivir treatments.
Journal: Journal of virology
Published: February 08, 2024
Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial.
Journal: Annals of internal medicine
Published: December 20, 2021
Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial.
Journal: Intensive care medicine
Published: July 13, 2021
Compassionate Use of Remdesivir in Children With Severe COVID-19.
Journal: Pediatrics
Published: February 10, 2021
Reply to Yan and Muller, "Remdesivir for COVID-19: Why Not Dose Higher?"
Journal: Antimicrobial agents and chemotherapy
Published: February 09, 2021
Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor.
Journal: Clinical pharmacokinetics
Published: January 07, 2021
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.
Journal: The New England journal of medicine
Published: December 28, 2020
PREVAIL IV: A Randomized, Double-Blind, 2-Phase, Phase 2 Trial of Remdesivir vs Placebo for Reduction of Ebola Virus RNA in the Semen of Male Survivors.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 05, 2020
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.
Journal: JAMA
Published: August 22, 2020
Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID-19, in Healthy Subjects.
Journal: Clinical and translational science
Published: June 03, 2020
Last Updated: 09/26/2026